MedPath
HSA Approval

DISUF OINTMENT 2% W/W

SIN14054P

DISUF OINTMENT 2% W/W

DISUF OINTMENT 2% W/W

November 22, 2011

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

OINTMENT

TOPICAL

Medical Information

D06AX01

fusidic acid

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Hovid Bhd.

Active Ingredients

Sodium Fusidate micronized

2.04% w/w

Fusidic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DISUF OINTMENT 2% W/W - HSA Approval | MedPath